LY3143921 hydrate T9064
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LY3143921 hydrate is an orally administered ATP-competitive�CDC7�inhibitor.
CAS nr:
1627696-53-0
Purity:
98%
Molecular Weight:
327,31
SMILES:
C[C@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F.O
Formula:
C16H14FN5O2
Pathway:
Cell Cycle/Checkpoint
Target:
CDK
